Skip to main content

Table 3 Baseline Measures of Outcome Variables for Study Participants in Chiapas and Costa Rica

From: Impact evaluation of a healthy lifestyle intervention to reduce cardiovascular disease risk in health centers in San José, Costa Rica and Chiapas, Mexico

  

Costa Rica Intervention Group

 

Costa Rica Comparison Group

  

Chiapas Intervention Group

 

Chiapas Comparison Group

 

Variable

N

Mean (95 % CI)

N

Mean (95 % CI)

p-value

N

Mean (95 % CI)

N

Mean (95 % CI)

p-value

Cognitive and Behavioral Outcomes

Knowledge Measure (0–45 points)

80

32.9 (31.7, 34.1)

86

32.9 (31.9, 33.9)

0.99

71

29.3 (27.7, 30.9)

80

27.4 (26.2, 28.5)

0.04

Self-efficacy Measure (0–15)

83

12.9 (12.4, 13.5)

86

12.6 (12.1, 13.1)

0.33

87

13.4 (13.0, 13.8)

81

13.1 (12.6, 13.6)

0.47

Stages of Change Measure (0–32)

76

22.6 (21.6, 23.7)

83

23.8 (22.7, 25.0)

0.14

86

22.3 (21.1, 23.4)

81

23.1 (22.1, 24.1)

0.27

Diet Index (0–14)

75

10.7 (10.2, 11.2)

81

10.9 (10.4, 11.4)

0.56

86

11.5 (11.1, 11.9)

81

10.5 (10.2, 10.9)

0.01

Meets Recommended minutes of physical activity per week (%)

80

66.25 %

86

50 %

0.03

87

75.9 %

81

45.7 %

<0.001

Clinical Outcomes

Body mass index (kg/m2) (%)

74

 

80

 

.012

87

 

81

 

.001

Normal weight (18.5 < 25)

 

17.6 %

 

10 %

  

8.4 %

 

28.4 %

 

Overweight (25 < 30)

 

50 %

 

33.8 %

  

41.0 %

 

44.4 %

 

Obese (> = 30)

 

32.4 %

 

56.2 %

  

50.6 %

 

27.2 %

 

Systolic BP (mmHg)

76

140.4 (135.8, 144.9)

76

127.6 (124.1, 131.2)

<.001

82

134.2 (128.9, 139.4)

81

136.0 (130.8, 141.2)

0.61

Diastolic BP (mmHg)

76

78.8 (70.3, 74.7)

76

72.5 (76.5, 81.1)

.001

82

75.7 (73.3, 78.1)

81

76.0 (73.6, 78.4)

0.84

Fasting Blood Glucose

70

127.4 (114.7, 140.1)

76

122.4 (113.6, 131.2)

0.52

83

145.8 (130.8, 160.8)

80

155.0 (139.4, 170.5)

0.40